ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/04/16 | 1,886 | 1,928 | 1,882 | 1,913 | +44 | +2.4% | 484,700 |
| 2021/04/15 | 1,825 | 1,880 | 1,819 | 1,869 | +58 | +3.2% | 504,500 |
| 2021/04/14 | 1,817 | 1,830 | 1,801 | 1,811 | -4 | -0.2% | 322,300 |
| 2021/04/13 | 1,855 | 1,858 | 1,811 | 1,815 | -39 | -2.1% | 536,500 |
| 2021/04/12 | 1,868 | 1,887 | 1,851 | 1,854 | +7 | +0.4% | 364,700 |
| 2021/04/09 | 1,840 | 1,865 | 1,834 | 1,847 | +25 | +1.4% | 485,900 |
| 2021/04/08 | 1,865 | 1,865 | 1,811 | 1,822 | -55 | -2.9% | 616,200 |
| 2021/04/07 | 1,918 | 1,918 | 1,868 | 1,877 | -41 | -2.1% | 487,500 |
| 2021/04/06 | 1,957 | 1,960 | 1,917 | 1,918 | -30 | -1.5% | 360,000 |
| 2021/04/05 | 1,995 | 2,006 | 1,947 | 1,948 | -41 | -2.1% | 385,300 |
| 2021/04/02 | 1,996 | 2,022 | 1,976 | 1,989 | -3 | -0.2% | 335,700 |
| 2021/04/01 | 1,975 | 2,012 | 1,954 | 1,992 | +20 | +1% | 458,000 |
| 2021/03/31 | 1,908 | 1,984 | 1,905 | 1,972 | +60 | +3.1% | 787,900 |
| 2021/03/30 | 1,890 | 1,934 | 1,880 | 1,912 | +41 | +2.2% | 656,500 |
| 2021/03/29 | 1,932 | 1,932 | 1,861 | 1,871 | -32 | -1.7% | 566,000 |
| 2021/03/26 | 1,919 | 1,920 | 1,890 | 1,903 | +6 | +0.3% | 414,400 |
| 2021/03/25 | 1,937 | 1,949 | 1,887 | 1,897 | -36 | -1.9% | 546,200 |
| 2021/03/24 | 1,968 | 1,973 | 1,923 | 1,933 | -55 | -2.8% | 569,600 |
| 2021/03/23 | 2,012 | 2,044 | 1,970 | 1,988 | -19 | -0.9% | 555,400 |
| 2021/03/22 | 2,005 | 2,027 | 1,982 | 2,007 | -24 | -1.2% | 566,200 |
| 2021/03/19 | 2,000 | 2,054 | 2,000 | 2,031 | -3 | -0.1% | 637,500 |
| 2021/03/18 | 2,018 | 2,050 | 2,001 | 2,034 | +27 | +1.3% | 628,900 |
| 2021/03/17 | 1,947 | 2,016 | 1,931 | 2,007 | +40 | +2% | 741,000 |
| 2021/03/16 | 1,914 | 1,972 | 1,905 | 1,967 | +48 | +2.5% | 610,700 |
| 2021/03/15 | 1,850 | 1,925 | 1,820 | 1,919 | +109 | +6% | 811,900 |
| 2021/03/12 | 1,798 | 1,832 | 1,785 | 1,810 | +33 | +1.9% | 546,600 |
| 2021/03/11 | 1,749 | 1,784 | 1,724 | 1,777 | +28 | +1.6% | 451,500 |
| 2021/03/10 | 1,752 | 1,775 | 1,735 | 1,749 | +9 | +0.5% | 456,400 |
| 2021/03/09 | 1,732 | 1,755 | 1,685 | 1,740 | -8 | -0.5% | 830,600 |
| 2021/03/08 | 1,846 | 1,850 | 1,742 | 1,748 | -85 | -4.6% | 816,700 |
| 2021/03/05 | 1,813 | 1,840 | 1,782 | 1,833 | +13 | +0.7% | 454,600 |
| 2021/03/04 | 1,826 | 1,846 | 1,802 | 1,820 | -23 | -1.2% | 367,700 |
| 2021/03/03 | 1,870 | 1,904 | 1,832 | 1,843 | -22 | -1.2% | 473,500 |
| 2021/03/02 | 1,817 | 1,878 | 1,813 | 1,865 | +10 | +0.5% | 381,700 |
| 2021/03/01 | 1,850 | 1,862 | 1,827 | 1,855 | +12 | +0.7% | 343,500 |
| 2021/02/26 | 1,820 | 1,883 | 1,784 | 1,843 | -2 | -0.1% | 651,700 |
| 2021/02/25 | 1,870 | 1,880 | 1,823 | 1,845 | +26 | +1.4% | 627,600 |
| 2021/02/24 | 1,804 | 1,845 | 1,787 | 1,819 | -4 | -0.2% | 852,500 |
| 2021/02/22 | 1,828 | 1,829 | 1,789 | 1,823 | +11 | +0.6% | 612,100 |
| 2021/02/19 | 1,848 | 1,871 | 1,760 | 1,812 | -60 | -3.2% | 1,242,800 |
| 2021/02/18 | 1,890 | 1,937 | 1,869 | 1,872 | -23 | -1.2% | 655,600 |
| 2021/02/17 | 1,937 | 1,945 | 1,883 | 1,895 | -50 | -2.6% | 746,900 |
| 2021/02/16 | 2,025 | 2,029 | 1,936 | 1,945 | -55 | -2.8% | 744,900 |
| 2021/02/15 | 1,970 | 2,040 | 1,942 | 2,000 | +142 | +7.6% | 1,601,100 |
| 2021/02/12 | 1,894 | 1,894 | 1,845 | 1,858 | -48 | -2.5% | 607,500 |
| 2021/02/10 | 1,904 | 1,933 | 1,894 | 1,906 | -15 | -0.8% | 317,400 |
| 2021/02/09 | 1,955 | 1,957 | 1,888 | 1,921 | -45 | -2.3% | 762,300 |
| 2021/02/08 | 1,988 | 1,994 | 1,963 | 1,966 | -22 | -1.1% | 467,300 |
| 2021/02/05 | 1,990 | 2,000 | 1,966 | 1,988 | -5 | -0.3% | 590,700 |
| 2021/02/04 | 2,025 | 2,032 | 1,972 | 1,993 | -32 | -1.6% | 480,700 |
851～
900
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
